Innovating Works

VISCOFAN

Activa
TRiAnkle: 3D BIOPRINTED PERSONALISED SCAFFOLDS FOR TISSUE REGENERATION OF ANKLE JOINT NATURIN VISCOFAN GMBH tramitó un H2020: Tendinopathies and osteoarthritis (OA) are extremely common and these injuries associate with high health and socioeconomic costs, long-term postoperative rehabilitation, and loss of productivity. To...
2021-01-01 | Financiado
ARDAT: Accelerating Research & Development for Advanced Therapies THE UNIVERSITY OF SHEFFIELD tramitó un H2020: Major current hurdles for wide clinical use of AAV vectors are attributable primarily to: (i) host elimination by both immune and non-immune sequestering mechanisms – such neutralization by host antib...
2020-11-01 | Financiado
BRAV3: Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged hearts UNIVERSIDAD DE NAVARRA tramitó un H2020: Ischemic heart disease is the main cause of death in the EU, straining patients and economies. Regenerative Medicine has failed at delivering a definitive solution, and even the breakthrough of cell r...
2020-01-01 | Financiado
RTC-2016-4911-1: Desarrollo clínico de una terapia celular para reparación cardíaca basada en ingeniería de tejidos VISCOFAN tramitó un AEI: A día de hoy las enfermedades cardiovasculares (CVD) son la principal causa de muerte en el mundo, afectando no únicamente al mundo industrializado, sino también a países en vías de desarrollo. Dentro...
2016-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.